NasdaqGS - Nasdaq Real Time Price USD

IGM Biosciences, Inc. (IGMS)

Compare
1.0500
-0.0100
(-0.94%)
As of 2:52:52 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,679
2,679
2,130
1,069
--
Operating Expense
211,259
211,259
265,591
229,025
165,323
Operating Income
-208,580
-208,580
-263,461
-227,956
-165,323
Net Non Operating Interest Income Expense
12,785
12,785
17,743
7,035
159
Other Income Expense
--
--
-20
-181
159
Pretax Income
-195,795
-195,795
-245,738
-221,102
-165,164
Tax Provision
--
--
678
--
--
Net Income Common Stockholders
-195,795
-195,795
-246,416
-221,102
-165,164
Diluted NI Available to Com Stockholders
-195,795
-195,795
-246,416
-221,102
-165,164
Basic EPS
-3.24
-3.24
-4.71
-5.32
-4.93
Diluted EPS
-3.24
-3.24
-4.71
-5.32
-4.93
Basic Average Shares
60,514.5460
60,514.5460
52,311.9580
41,543.9540
33,479.7820
Diluted Average Shares
60,514.5460
60,514.5460
52,311.9580
41,543.9540
33,479.7820
Total Operating Income as Reported
-208,580
-208,580
-263,461
-227,956
-165,323
Total Expenses
211,259
211,259
265,591
229,025
165,323
Net Income from Continuing & Discontinued Operation
-195,795
-195,795
-246,416
-221,102
-165,164
Normalized Income
-195,795
-195,795
-246,416
-221,102
-165,164
Interest Income
12,785
12,785
17,743
7,035
159
Net Interest Income
12,785
12,785
17,743
7,035
159
EBIT
-208,580
-208,580
-263,461
-227,956
-165,323
EBITDA
-199,468
-199,468
-255,184
-221,881
-160,839
Reconciled Depreciation
9,112
9,112
8,277
6,075
4,484
Net Income from Continuing Operation Net Minority Interest
-195,795
-195,795
-246,416
-221,102
-165,164
Normalized EBITDA
-199,468
-199,468
-255,184
-221,881
-160,839
Tax Rate for Calcs
--
--
0.0002
--
--
12/31/2021 - 9/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XNCR Xencor, Inc.
8.41
-4.54%
 
YMAB Y-mAbs Therapeutics, Inc.
4.3300
-2.70%
 
THRD Third Harmonic Bio, Inc.
3.4700
-0.85%
 
CRGX CARGO Therapeutics, Inc.
4.0500
0.00%
 
IMAB I-Mab
0.6701
-2.71%
 
TIL Instil Bio, Inc.
14.56
-3.70%
 
MRSN Mersana Therapeutics, Inc.
0.2805
-7.61%
 
ADVM Adverum Biotechnologies, Inc.
3.3000
-7.84%
 
NKTX Nkarta, Inc.
1.5100
-3.81%
 
PRLD Prelude Therapeutics Incorporated
0.6648
+0.02%